Per Soelberg Sørensen
Professor emeritus, Professor, emeritus
- 2014
- Published
Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial
Romme Christensen, J., Ratzer, R., Börnsen, L., Lyksborg, M., Garde, E., Dyrby, T. B., Siebner, Hartwig Roman, Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 29 Apr 2014, In: Neurology. 82, 17, p. 1499-1507 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
Vollmer, T. L., Sørensen, Per Soelberg, Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., Arnold, D. L. & BRAVO Study Group, B. S. G., Apr 2014, In: Journal of Neurology. 261, 4, p. 773-783 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
Hegen, H., Millonig, A., Bertolotto, A., Comabella, M., Giovanonni, G., Guger, M., Hoelzl, M., Khalil, M., Killestein, J., Lindberg, R., Malucchi, S., Mehling, M., Montalban, X., Polman, C. H., Rudzki, D., Schautzer, F., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg & Deisenhammer, F., Apr 2014, In: Multiple Sclerosis. 20, 5, p. 577-587 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility
Damotte, V., Guillot-Noel, L., Patsopoulos, N. A., Madireddy, L., El Behi, M., De Jager, P. L., Baranzini, S. E., Cournu-Rebeix, I., Fontaine, B., International Multiple Sclerosis Genetics Consortium, I. M. S. G. C. & Sørensen, Per Soelberg, Mar 2014, In: Genes and Immunity. 15, 2, p. 126-132 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
Sørensen, Per Soelberg, Lisby, S., Grove, R., Derosier, F., Shackelford, S., Havrdova, E., Drulovic, J. & Filippi, M., 18 Feb 2014, In: Neurology. 82, 7, p. 573-581 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
Liu, Yawei, Carlsson, R., Comabella, M., Wang, J., Kosicki, M. K., Carrion, B., Hasan, M., Wu, X., Montalban, X., Dziegiel, Morten Hanefeld, Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Helin, K. & Issazadeh-Navikas, Shohreh, 16 Feb 2014, In: Nature Medicine.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Gender and autoimmune comorbidity in multiple sclerosis
Magyari, M., Koch-Henriksen, N., Pfleger, C. C. & Sørensen, Per Soelberg, 5 Feb 2014, In: Multiple Sclerosis. 20, 9, p. 1244-1251 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis
Møller, M., Søndergaard, H. B., Koch-Henriksen, N., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Oturai, A. B., Jan 2014, In: Acta Neurologica Scandinavica. 129, 1, p. 27-31 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Multiple sclerosis impairs regional functional connectivity in the cerebellum
Dogonowski, A., Andersen, K. W., Madsen, K. H., Sørensen, Per Soelberg, Paulson, Olaf B., Blinkenberg, M. & Siebner, Hartwig Roman, 2014, In: NeuroImage: Clinical. 4, p. 130–138 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prediction of response to interferon therapy in multiple sclerosis
Sellebjerg, Finn Thorup, Søndergaard, H. B., Koch-Henriksen, N., Sørensen, Per Soelberg & Oturai, A. B., 2014, In: Acta Neurologica Scandinavica. 130, 4, p. 268-275 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 11025
Most downloads
-
245
downloads
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
187
downloads
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
162
downloads
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
Research output: Contribution to journal › Journal article › Research › peer-review
Published